RAP2B and colorectal carcinoma: Collectively, we demonstrated that exosome-miR-22-3p derived from hBMSCs suppressed CRC cells proliferation and invasion via suppressing RAP2B expression to inhibit PI3K/AKT pathway, proposing that miR-22-3p might become a potential marker for early diagnosis and treatment of CRC patients.